Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
52.20
-0.20 (-0.38%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
64
65
Next >
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
May 29, 2024
From
Bristol Myers Squibb
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 28, 2024
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
May 28, 2024
Via
Benzinga
(BMY) - Analyzing Bristol-Myers Squibb's Short Interest
May 23, 2024
Via
Benzinga
This Unpopular Dividend Stock Is a Buy
May 23, 2024
This top pharma stock has fallen too far.
Via
The Motley Fool
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
May 21, 2024
Via
Benzinga
3 Blue-Chip Stocks to Buy at 52-Week Lows in May
May 27, 2024
These three blue-chip stocks at a 52-week low could provide investors with a good opportunity to open a new position or double an old one.
Via
InvestorPlace
S&P 500 Earnings Dashboard 24Q1 - Saturday, May 25
May 25, 2024
Of the 480 companies in the S&P 500 that have reported earnings to date for 24Q1, 77.9% reported above analyst expectations. This compares to a long-term average of 66%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Retail Earnings & Consumer Spending: A Closer Look
May 25, 2024
The U.S. economy is chugging along, with growth moderately decelerating under the Fed’s tight monetary policy. Most of the Q1 earnings season is behind us, with results from 481 S&P 500 companies...
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Economy
Interest Rates
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
May 24, 2024
Via
Benzinga
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
May 24, 2024
Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in metastatic pancreatic cancer. FDA submission for recurrent KRAS mutant...
Via
Benzinga
Exposures
Product Safety
Bonds Break Down And Send Everyone To Cash
May 23, 2024
This situation is where the danger, the opportunity, and the action are right now.
Via
Talk Markets
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
May 23, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
May 23, 2024
From
Bristol Myers Squibb
Via
Business Wire
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M
May 22, 2024
A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the health risks of their blood thinner Plavix. The ruling follows a previous...
Via
Benzinga
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries
May 22, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
May 21, 2024
From
Bristol Myers Squibb
Via
Business Wire
1 Stock I Wouldn't Touch With a 10-Foot Pole
May 21, 2024
This stock isn't as safe as it seems, and now isn't the time to dabble.
Via
The Motley Fool
3 Bargain Stocks to Buy Now: May 2024
May 21, 2024
These bargain stocks to buy provide substantial upside since they are trading at a significant discount to their historical multiples.
Via
InvestorPlace
Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
May 21, 2024
From
Bristol Myers Squibb
Via
Business Wire
Large Cap Biopharmaceuticals Performance
May 20, 2024
The biotech sector remains a laggard YTD as can be seen by the IBB.
Via
Talk Markets
Insider Trading is Good News for These Stocks
May 20, 2024
Insiders are buying these hot stocks that have ample upside for investors. The list includes pharma, entertainment, and financial stocks and Berkshire buys.
Via
MarketBeat
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
May 17, 2024
Cantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target. AbbVie is set to manage Humira biosimilar erosion, drive growth with Skyrizi, Rinvoq, and emraclidine,...
Via
Benzinga
Walmart Earnings And The State Of The Consumer
May 16, 2024
This earnings season showed a notable acceleration in the earnings growth pace, which produces a reassuring earnings backdrop for the market.
Via
Talk Markets
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma
May 16, 2024
FDA grants accelerated approval for Bristol Myers Squibb's Breyanzi, a CAR T cell therapy, for relapsed or refractory follicular lymphoma. Breyanzi is included in NCCN guidelines and shows high...
Via
Benzinga
Exposures
Product Safety
New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
May 16, 2024
From
Bristol Myers Squibb
Via
Business Wire
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
May 16, 2024
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
May 15, 2024
From
Bristol Myers Squibb
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 14, 2024
Via
Benzinga
Dividend Capture Captains: The 3 Best Blue-Chip Stocks for Tactical Traders
May 14, 2024
Using these capture-the-dividend stock strategy for tactical traders can be profitable with high-yield blue-chips.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.